Subjective cognitive decline predicts future dementia risk, study finds

FHS
July 8, 2024
3:12 am

A study in JAMA Psychiatry finds that subjective cognitive decline (SCD) significantly predicts the risk of mild cognitive impairment (MCI), Alzheimer’s disease (AD), and all-cause dementia in older adults.

As AI proliferates, biopharma companies seek to harness it in clinical trials

For around 20 years, Avi Veidman spent his days in the Israeli intelligence community, analyzing satellite images. That was until 2017, when he founded a

April 3, 2024

MGI and Bio-Medical Science Sign MOU to Deliver Cutting-Edge Sequencing Platforms and Reagents to South Korea

MGI, a company committed to building core tools and technology to lead life science, today announced MOU with Bio-Medical Science Co., Ltd. (“BMS”) to expand

September 18, 2023

Tenpoint raises funds to develop cell therapies for vision loss

The company will develop a regenerative medicine platform that could substitute multiple types of cells destroyed by inherited and age-linked ocular ailments. Credit: wavebreakmedia /

July 13, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.